Drug intelligence / Profile preview

Technospiron

Development stage
Unknown
Lead developer
Technopharm
Modality
Small Molecules
Administration
Oral
01

Overview

Technospiron is a monophasic combined oral contraceptive pill (COCP) containing 0.03 mg of ethinyl estradiol and 3 mg of drospirenone. Ethinyl estradiol is a synthetic estrogen that suppresses follicle-stimulating hormone (FSH) and provides endometrial stability, while drospirenone is a fourth-generation progestin that inhibits ovulation by suppressing luteinizing hormone (LH). Drospirenone is chemically related to spironolactone and possesses unique anti-mineralocorticoid and anti-androgenic properties, which help minimize estrogen-related water retention and androgenic side effects like acne. In clinical research conducted by Benha University, Technospiron was evaluated for its efficacy in managing symptomatic abnormal uterine bleeding (AUB) specifically related to a uterine niche (cesarean scar defect), where it works by thinning the endometrial lining and regulating the menstrual cycle to reduce niche-related spotting and heavy bleeding.

Brand names
Technospiron
Other names
monophasic combined oral contraceptive pillethinyl estradiol + drospirenoneEE/DRSPTechnospiron 0.03/3 mg
02

Targets

ER (Estrogen receptor)PR (Progesterone receptor)

Beyond the preview

Go deeper on Technospiron.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Technospiron.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call